GoodData Announces $45 Million Credit Facility from J.P. Morgan to Accelerate Enterprise Adoption of Cloud-Native Business Analytics
July 27, 2021 12:00 ET
|
GoodData
SAN FRANCISCO, July 27, 2021 (GLOBE NEWSWIRE) -- GoodData, the leader in Data as a Service (DaaS) analytics infrastructure, today announced the closing of a $45 million credit facility from J.P....
CSX Chief Executive Officer to Address J.P. Morgan Industrials Conference
March 09, 2021 10:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer James M. Foote will address the J.P. Morgan Industrials Conference virtually on...
Millicom to present at JP Morgan Global High Yield & Leveraged Finance Conference
March 03, 2021 08:00 ET
|
Millicom International Cellular S.A.
Millicom to present at JP Morgan Global High Yield & Leveraged Finance Conference Luxembourg, March 3, 2021 – Millicom International Cellular S.A. (“Millicom”) announces that Millicom’s Chief...
THC Therapeutics Has Joined the Las Vegas Medical Marijuana Association.
February 04, 2021 07:20 ET
|
THC Therapeutics Inc
The company will utilize the connections of the LVMMA to raise capital, and seek mergers & acquisitions. THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company,...
Global Blockchain in Banking Sector Market – Internet of Things (IoT) devices, Blockchain-as-a service boosting market growth - by PMI
January 21, 2021 11:05 ET
|
PMI
Covina CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cryptocurrencies such as bitcoin are slowly making a transition from speculative investment instruments to payments. Special attention to payment habits...
Intrommune to Participate in BIO @ JPM During “J.P. Morgan Week 2021”
January 07, 2021 17:35 ET
|
Intrommune Therapeutics
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, will...
Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted therapies to inhibit frontier...
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
September 15, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
Rafael Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
January 13, 2020 09:00 ET
|
Rafael Pharmaceuticals, Inc.
Cranbury, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that...